Overview
If you’ve been comparing prop firms, DNA Funded has probably come up. It has been running since 2024 out of Unknown. The route to funding is a 1-Step / 2-Step / 3-Step evaluation, and you can scale to $600000 in funded capital. Here’s what we found testing it ourselves.
Getting funded runs through a 1-Step / 2-Step / 3-Step evaluation, with drawdown tracked on a Static basis — worth understanding before you start, since it decides how much room you really have on a bad day. You’ll be trading on DXTrade, TradeLocker, keeping up to 90% of what you make. The firm advertises Standard cycle payouts. The tabs above break each of these down — rules, platforms, and payout experience — with the fine print that actually matters.
✅ What We Like
- Over 800 tradeable instruments. That's among the widest access on this entire list
- Backed by DNA Markets, a regulated broker — a stronger trust signal than several unregulated names here
- Spreads advertised from 0.0 pips, genuinely competitive if cost matters to you
- Gets you in starting at $49
❌ What Could Be Better
- Launched in 2024 — the shortest track record on this list by a wide margin, so payout consistency over time is simply unproven
- There isn't much independent long-run review coverage yet, compared to firms that have been around since 2015 or 2016
- Only two platforms supported, versus FTMO's three
Score Breakdown
Evaluation Rules
The drawdown here is static — your loss limit is fixed from the starting balance and never moves up as you profit. If you start a $100K account with a 10% max drawdown, the floor stays at $90K no matter how high your equity climbs. This is the most forgiving model for traders who bank profits early, because winning never shrinks your room for error.
Trading Rules at a Glance
| Rule | Status |
|---|---|
| News Trading | Allowed ✓ |
| Weekend Holding | Allowed ✓ |
| EAs / Robots | Allowed ✓ |
| Copy Trading | Restricted |
| Challenge Fee Refundable | Yes ✓ |
| Drawdown Type | Static |
Trading Platforms
MT4's successor — faster backtesting, more timeframes, depth-of-market, and native support for more asset classes. Most newer firms have standardised on it.
Known for clean charting and transparent level-II pricing. Favoured by scalpers for its execution detail. Rare among prop firms, so support here is a genuine differentiator.
A white-label platform many newer prop firms adopted after MetaTrader licensing tightened. Functional, web-based, though with a smaller tool ecosystem.
Supported by DNA Funded — check the firm's site for platform-specific account details.
Payouts
Payout reliability matters more than any headline number — a generous split means nothing if withdrawals stall. DNA Funded was processing withdrawals in Standard cycle when we last verified this review, and the challenge fee is refunded once you reach your first payout — effectively making the evaluation free if you pass and withdraw. If you've withdrawn from this firm recently and your experience differs, use the report link at the bottom of this review.
Our Honest Verdict
The regulated-broker backing and the instrument breadth are genuinely attractive, and the pricing is aggressive in a good way. The catch is just time — a 2024 launch means there's no multi-year track record yet, the kind that makes FTMO or The5ers a known quantity. Worth a smaller test position while the history builds.
Spot something outdated? Report it here and we'll check it within 48 hours.
Leave a Review